Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
21 |
Material Type: Artigo
|
Novel Plasmid-Mediated tet (X5) Gene Conferring Resistance to Tigecycline, Eravacycline, and Omadacycline in a Clinical Acinetobacter baumannii IsolateWang, Liyuan ; Liu, Dejun ; Lv, Yuan ; Cui, Lanqing ; Li, Yun ; Li, Tianmeng ; Song, Huangwei ; Hao, Yuxin ; Shen, Jianzhong ; Wang, Yang ; Walsh, Timothy RAntimicrobial agents and chemotherapy, 2019-12, Vol.64 (1) [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
22 |
Material Type: Artigo
|
Characterization of TMexCD3-TOprJ3, an RND-Type Efflux System Conferring Resistance to Tigecycline in Proteus mirabilis, and Its Associated Integrative Conjugative ElementWang, Qian ; Peng, Kai ; Liu, Yuan ; Xiao, Xia ; Wang, Zhiqiang ; Li, RuichaoAntimicrobial agents and chemotherapy, 2021-06, Vol.65 (7), p.e0271220-e0271220 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
23 |
Material Type: Artigo
|
Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysisGong, Jinhong ; Su, Dan ; Shang, Jingjing ; Yu, Hai ; Du, Guantao ; Lin, Ying ; Sun, Zhiqiang ; Liu, GuangjunMedicine (Baltimore), 2019-09, Vol.98 (38), p.e17091 [Periódico revisado por pares]United States: Wolters Kluwer HealthTexto completo disponível |
|
24 |
Material Type: Artigo
|
A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumanniiKarakonstantis, StamatisJournal of chemotherapy (Florence), 2021-02, Vol.33 (1), p.1-11 [Periódico revisado por pares]England: Taylor & FrancisSem texto completo |
|
25 |
Material Type: Artigo
|
Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumoniaDimopoulos, G. ; Almyroudi, M.P. ; Kapralos, I. ; Apostolopoulou, O. ; Flevari, A. ; Nicolau, D.P. ; Dokoumetzidis, A.International journal of antimicrobial agents, 2022-01, Vol.59 (1), p.106487-106487, Article 106487 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
26 |
Material Type: Artigo
|
Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective StudyPhillips, Emma C ; Warren, Cirle A ; Ma, Jennie Z ; Madden, Gregory RAntimicrobial agents and chemotherapy, 2022-06, Vol.66 (6), p.e0000122-e0000122 [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
27 |
Material Type: Artigo
|
Antibacterial Efficacy and Discoloration Potential of Endodontic Topical AntibioticsAlSaeed, Turky ; Nosrat, Ali ; Melo, Mary Anne ; Wang, Ping ; Romberg, Elaine ; Xu, Huakun ; Fouad, Ashraf F.Journal of endodontics, 2018-07, Vol.44 (7), p.1110-1114 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
|
28 |
Material Type: Artigo
|
Acute pancreatitis caused by tigecycline: A case report and literature reviewWang, Peng-Fei ; Zou, Hong ; Zhu, Ji-Hong ; Shi, Fang-EMedicine (Baltimore), 2021-12, Vol.100 (51), p.e28245 [Periódico revisado por pares]United States: Lippincott Williams & WilkinsTexto completo disponível |
|
29 |
Material Type: Artigo
|
In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessusKaushik, Amit ; Ammerman, Nicole C ; Martins, Olumide ; Parrish, Nicole M ; Nuermberger, Eric LAntimicrobial agents and chemotherapy, 2019-06, Vol.63 (6) [Periódico revisado por pares]United States: American Society for MicrobiologyTexto completo disponível |
|
30 |
Material Type: Artigo
|
Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic studyBroeker, A ; Wicha, S G ; Dorn, C ; Kratzer, A ; Schleibinger, M ; Kees, F ; Heininger, A ; Kees, M G ; Häberle, HCritical care (London, England), 2018-12, Vol.22 (1), p.341-341, Article 341 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |